Subscribe to stay informed!
Doctors at Pennsylvania Hospital in Philadelphia recently performed a revolutionary procedure by temporarily implanting a brain-computer interface device onto a patient’s brain, writes…
Mid Penn Bank is continuing its partnership with the Basser Center for BRCA at Penn Medicine in Philadelphia.
On October 3, Mid Penn Bank President…
University City-based Vitara Biomedical is currently working on an artificial womb for premature babies and is getting closer to human clinical trials, writes Liz…
After spending years advocating against the FDA-enacted restrictions that critics believe to be discriminatory against gay and bisexual men, Adam Joseph donated blood for…
A West Chester pharmaceutical company finally achieved federal approval of a new drug candidate that treats a contagious skin disease, writes John George for the…
West Chester-based Verrica Pharmaceuticals is expecting to raise $32.5 million from the sale of 750,000 shares of its common stock at $6…
West Chester’s Verrica Pharmaceuticals is seeking FDA approval to market the drug “Ycanth,” which treats a skin condition, writes John George for the Philadelphia…
Malvern-based biopharmaceutical company Galera Therapeutics is filing for FDA approval of a new drug. The treatment, avasopasem, helps radiotherapy-induced severe oral mucositis, or…
Malvern-based Ocugen has submitted a request to the Food and Drug Administration for Emergency Use Authorization (EUA) of its COVID-19 vaccine candidate for…
A new study by the Centers for Disease Control and Prevention (CDC) found the Pfizer COVID-19 vaccine to be 93 percent effective in protecting…
Melior Pharmaceuticals, an Exton-based company that specializes in repositioning old medicines for new uses, has been given the green light by the FDA to…
West Chester-based Verrica Pharmaceuticals saw its stock plunge by nearly 22 percent after the FDA voiced concerns about its lead drug candidate, VP-102…
Devon-based Zynerba Pharmaceuticals has received “Fast Track” status from the FDA for its synthetic cannabidiol drug intended to treat symptoms associated with Fragile X…
If approved by the FDA to treat post-traumatic stress disorder, MDMA – the party drug known as “Molly” or “ecstasy” – will be prepared for shipping…
Gawthrop Greenwood and Volunteer English Program
John Rafferty, an attorney with the law firm Gawthrop Greenwood, has been elected to the board of the Volunteer…
The rampant drug abuse linked to a Malvern-based opioid pain medication has led to the U.S. Food and Drug Administration’s first-ever…
Wayne’s Egalet got some good news last week from the Food and Drug Administration after it approved the pharmaceutical company’s abuse-resistant opioid…
Food safety is a huge concern to all of us from farm producer to ultimate food consumer. According to the Centers for Disease Control and…
Before we send you to this site, please subscribe to our daily newsletter.